Bonneville-Levard, Alice http://orcid.org/0000-0002-5214-3711
Frappaz, Didier
Tredan, Olivier
Lavergne, Emilie
Corset, Véronique
Agrapart, Vincent
Chabaud, Sylvie
Pissaloux, Daniel
Wang, Qing
Attignon, Valery
Cartalat, Stéphanie
Ducray, François
Thomas-Maisonneuve, Laure
Honnorat, Jérôme
Meyronet, David
Taillandier, Luc
Blonski, Marie
Viari, Alain
Baudet, Christian
Sohier, Emilie
Lantuejoul, Sylvie
Paindavoine, Sandrine
Treilleux, Isabelle
Rodriguez, Christine
Pérol, David
Blay, Jean-Yves
Funding for this research was provided by:
Institut National Du Cancer (DGOS-INCA-46644)
BPI financement European community (E8983-PREDICTIV)
Agence national de la recherche (ANR Labex DEvweCAN 10-LABX-0061)
Ligue Contre le Cancer
Centre Leon Berard
Fondation ARC
European Commission (EURACAN 739521)
Article History
Received: 23 December 2020
Accepted: 15 June 2021
First Online: 5 November 2021
Declarations
:
: The authors have declared no potential conflicts of interest.
: The study received local approval (Ethics committee of Lyon Sud-Est IV) and was conducted in accordance with the Good Clinical Practice guidelines of the International Conference on Harmonization, and the Declaration of Helsinki, and relevant French and European laws and directives.
: All patients provided written informed consent.
: All authors wrote, have read, and approved the final manuscript.